Delving into the Latest Updates on Paradigm Biopharmaceuticals (USA), Inc. with Synapse

Overview

Tags

Otorhinolaryngologic Diseases

Nervous System Diseases

Congenital Disorders

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Endocrinology and Metabolic Disease	1
Immune System Diseases	1
Infectious Diseases	1
Nervous System Diseases	1

Top 5 Drug Type	Count

Small molecule drug	1

Top 5 Target	Count

RT(Viral reverse transcriptase)	1

The purpose of this study is to measure the duration of treatment effect with subcutaneous injections of pentosan polysulfate sodium (PPS) compared with placebo in adult participants with knee osteoarthritis (OA) pain. The study duration will be up to 34 weeks.
Participants who completed pDay 162 of Study PARA_OA_002 (i.e. did not discontinue/withdraw prematurely from the parent study) will be invited to participate.

Start Date24 Jun 2023

Sponsor / Collaborator

Paradigm Biopharmaceuticals (USA), Inc.

NCT04809376 / Active, not recruitingPhase 2/3

A 2-stage, Adaptive, Randomised, Double-blind, Placebo-controlled, Multicentre Study to Evaluate Dose and Treatment Effect of Pentosan Polysulfate Sodium Compared With Placebo in Participants With Knee Osteoarthritis Pain

The purpose of this study is to measure the change in pain and function with subcutaneous injections of pentosan polysulfate sodium (PPS) compared with subcutaneous injections of placebo in participants with knee osteoarthritis pain.
Study details include:
The study duration will be up to 31 weeks per participant
The treatment duration will be 6 weeks.
The visit frequency will be twice weekly during treatment.
The visit frequency will be every 4 weeks during the follow-up period.

Start Date19 Oct 2021

Sponsor / Collaborator

Paradigm Biopharmaceuticals (USA), Inc.

100 Clinical Results associated with Paradigm Biopharmaceuticals (USA), Inc.

Login to view more data

0 Patents (Medical) associated with Paradigm Biopharmaceuticals (USA), Inc.

Login to view more data

100 Deals associated with Paradigm Biopharmaceuticals (USA), Inc.

Login to view more data

100 Translational Medicine associated with Paradigm Biopharmaceuticals (USA), Inc.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 22 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 3 Clinical

1

Login to view more data